{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:43:10Z","timestamp":1776998590046,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract {4\u20135}<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of invasive mechanical ventilation in newborns has several risks, including ventilator-induced lung injury, ventilation-associated pneumonia, and hyperventilation leading to potential brain injury, prolonged hospitalisations, and increased mortality. The SafeBoosC-IIIv trial aims to assess the benefits and harms of treatment guided by cerebral oximetry monitoring in newborns receiving invasive mechanical ventilation within the first 28\u00a0days from birth. The SafeBoosC consortium is a global network of neonatologists from multiple neonatal intensive care units worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The SafeBoosC-IIIv trial is an investigator-initiated, multinational, randomised, pragmatic, superiority phase III clinical trial. The trial will be conducted in two steps. This is a protocol for step one. The objective of step one is to assess if treatment guided by cerebral oximetry monitoring according to the SafeBoosC treatment guideline compared with usual care in newborns receiving invasive mechanical ventilation increases the number of hospital-free days. The participants will be newborns with a gestational age more than or equal to 28\u2009+\u20090\u00a0weeks, postnatal age less than 28\u00a0days, expected to receive invasive mechanical ventilation (intubation) for at least 24\u00a0h, and a cerebral oximeter available so monitoring can be started within 6 h after initiation of invasive mechanical ventilation. Exclusion criteria will be suspicion of or confirmed brain injury or congenital heart malformation likely to require surgery. A total of 1,610 participants will be randomised 1:1 to treatment guided by cerebral oximetry monitoring or usual care. The primary outcome will be hospital-free days, and the secondary outcomes will be serious adverse events and invasive mechanical ventilation-free days. All outcomes will be assessed at 90\u00a0days after randomisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The SafeBoosC-IIIv trial has several strengths, including detailed predefined methodology, a high degree of external validity due to centres in several countries, and the trial will be built upon the already established SafeBoosC consortium and the experience from the previous SafeBoosC-II and SafeBoosC-III trials. The SafeBoosC-IIIv trial has limitations, including current lack of funding for step two, lack of blinding of the clinical staff, and the clinicians may have limited experience in using the device.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov: NCT05907317, registered 8 June 2023,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05907317?cond=NCT05907317&amp;rank=1\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT05907317?cond=NCT05907317&amp;rank=1<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-026-09631-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:31:37Z","timestamp":1773768697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment guided by cerebral oximetry in newborns receiving invasive mechanical ventilation: study protocol for step one of the SafeBoosC-IIIv randomised clinical trial"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-4694","authenticated-orcid":false,"given":"Caroline Barkholt","family":"Kamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne Juul","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias L\u00fchr","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelina","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Naulaers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte Holst","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Isabel Skov","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Szczapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Livia","family":"Ognean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saudamini","family":"Nesargi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Musante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Chalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Lakhwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato S.","family":"Procianoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih","family":"Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Hagmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Fabres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laishuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Schm\u00f6lzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Piris-Borregas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Mohora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Zafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosmas","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Alsina-Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariae","family":"Baik-Schneditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Serrano","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Griesmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Hatzidaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashidhar","family":"A","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Dassios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorm","family":"Greisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus Christian","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"5","key":"9631_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/siny.2002.0129","volume":"7","author":"MA Attar","year":"2002","unstructured":"Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002;7(5):353\u201360.","journal-title":"Semin Neonatol"},{"issue":"1","key":"9631_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00003246-199301000-00024","volume":"21","author":"JC Parker","year":"1993","unstructured":"Parker JC, Hernandez LA, Peevy KJ. Mechanisms of ventilator-induced lung injury. Crit Care Med. 1993;21(1):131\u201343.","journal-title":"Crit Care Med"},{"key":"9631_CR3","unstructured":"Overview of mechanical ventilation in neonates. 2021.\u00a0Available from: https:\/\/www.uptodate.com\/contents\/overview.of.mechanical.ventilation.in.neonates?search=mechanical%20ventilation&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#references. Cited 30\/01\/2024."},{"issue":"2","key":"9631_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ymgme.2009.01.015","volume":"97","author":"PO Nkadi","year":"2009","unstructured":"Nkadi PO, Merritt TA, Pillers DA. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol Genet Metab. 2009;97(2):95\u2013101.","journal-title":"Mol Genet Metab"},{"key":"9631_CR5","doi-asserted-by":"crossref","unstructured":"Miller JD, Carlo WA. Pulmonary complications of mechanical ventilation in neonates. Clin Perinatol. 2008;35(1):273\u201381, x-xi.","DOI":"10.1016\/j.clp.2007.11.004"},{"key":"9631_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fped.2015.00097","volume":"3","author":"SK Barton","year":"2015","unstructured":"Barton SK, Tolcos M, Miller SL, Roehr CC, Schmolzer GM, Davis PG, et al. Unraveling the links between the initiation of ventilation and brain injury in preterm infants. Front Pediatr. 2015;3:97.","journal-title":"Front Pediatr"},{"issue":"6","key":"9631_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/dmcn.15136","volume":"64","author":"ML Larsen","year":"2022","unstructured":"Larsen ML, Rackauskaite G, Greisen G, Laursen B, Uldall P, Krebs L, et al. Declining prevalence of cerebral palsy in children born at term in Denmark. Dev Med Child Neurol. 2022;64(6):715\u201322.","journal-title":"Dev Med Child Neurol"},{"key":"9631_CR8","doi-asserted-by":"publisher","first-page":"1363472","DOI":"10.3389\/fped.2024.1363472","volume":"12","author":"V Vargas Caicedo","year":"2024","unstructured":"Vargas Caicedo V, de la Plaza San Frutos M, Sosa Reina MD, Garcia Arrabe M, Salniccia F, Reina Aguilar C, et al. Effects of mechanical ventilation on neurodevelopment at 12 months in preterm low birth weight pediatric patients: a systematic review. Front Pediatr. 2024;12:1363472.","journal-title":"Front Pediatr"},{"key":"9631_CR9","doi-asserted-by":"crossref","unstructured":"Hansen ML, Hyttel-Sorensen S, Jakobsen JC, Gluud C, Kooi EMW, Mintzer J, et al. Cerebral near-infrared spectroscopy monitoring (NIRS) in children and adults: a systematic review with meta-analysis. Pediatr Res. 2024;96(4):856-867.","DOI":"10.1038\/s41390-022-01995-z"},{"key":"9631_CR10","doi-asserted-by":"crossref","unstructured":"Baik-Schneditz N, Schwaberger B, Bresesti I, Fuchs H, Lara I, Nakstad B, et al. Fetal to neonatal transition: what additional information can be provided by cerebral near infrared spectroscopy? Pediatr Res. 2024;96(3):818.","DOI":"10.1038\/s41390-022-02173-x"},{"key":"9631_CR11","doi-asserted-by":"publisher","first-page":"g7635","DOI":"10.1136\/bmj.g7635","volume":"350","author":"S Hyttel-Sorensen","year":"2015","unstructured":"Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, et al. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ. 2015;350:g7635.","journal-title":"BMJ"},{"issue":"16","key":"9631_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMoa2207554","volume":"388","author":"ML Hansen","year":"2023","unstructured":"Hansen ML, Pellicer A, Hyttel-Sorensen S, Ergenekon E, Szczapa T, Hagmann C, et al. Cerebral oximetry monitoring in extremely preterm infants. N Engl J Med. 2023;388(16):1501\u201311.","journal-title":"N Engl J Med"},{"issue":"1","key":"9631_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13063-023-07699-x","volume":"24","author":"ML Vestager","year":"2023","unstructured":"Vestager ML, Hansen ML, Rasmussen MI, Hahn GH, Hyttel-Sorensen S, Pellicer A, et al. The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the safeboosc-IIIv randomised clinical trial. Trials. 2023;24(1):696.","journal-title":"Trials"},{"key":"9631_CR14","doi-asserted-by":"publisher","first-page":"e081660","DOI":"10.1136\/bmj-2024-081660","volume":"389","author":"A Hrobjartsson","year":"2025","unstructured":"Hrobjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081660.","journal-title":"BMJ"},{"issue":"3","key":"9631_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000351346","volume":"104","author":"A Pellicer","year":"2013","unstructured":"Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagalli M, et al. The safeboosc phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology. 2013;104(3):171\u20138.","journal-title":"Neonatology"},{"key":"9631_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/978-1-4939-3023-4_52","volume":"876","author":"S Kleiser","year":"2016","unstructured":"Kleiser S, Hyttel-Sorensen S, Greisen G, Wolf M. Comparison of near-infrared oximeters in a liquid optical phantom with varying Intralipid and blood content. Adv Exp Med Biol. 2016;876:413\u20138.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"9631_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1364\/BOE.9.000086","volume":"9","author":"S Kleiser","year":"2018","unstructured":"Kleiser S, Ostojic D, Andresen B, Nasseri N, Isler H, Scholkmann F, et al. Comparison of tissue oximeters on a liquid phantom with adjustable optical properties: an extension. Biomed Opt Express. 2018;9(1):86\u2013101.","journal-title":"Biomed Opt Express"},{"issue":"8","key":"9631_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1164\/rccm.202104-1063PP","volume":"204","author":"CL Auriemma","year":"2021","unstructured":"Auriemma CL, Taylor SP, Harhay MO, Courtright KR, Halpern SD. Hospital-free days: a pragmatic and patient-centered outcome for trials among critically and seriously ill patients. Am J Respir Crit Care Med. 2021;204(8):902\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"9631_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","volume":"294","author":"C Binanay","year":"2005","unstructured":"Binanay C, Califf RM, Hasselblad V, O\u2019Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294(13):1625\u201333.","journal-title":"JAMA"},{"key":"9631_CR20","doi-asserted-by":"crossref","unstructured":"Lopes RD, Macedo AVS, de Barros ESPGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254\u201364.","DOI":"10.1001\/jama.2020.25864"},{"issue":"01","key":"9631_CR21","first-page":"2","volume":"06","author":"J Jakobsen","year":"2015","unstructured":"Jakobsen J, Tamborrino M, Winkel P, Haase N, Perner A, Wetterslev J, et al. Count Data Analysis in Randomised Clinical Trials. J Biom Biostat. 2015;06(01):2.","journal-title":"J Biom Biostat."},{"issue":"Suppl 1","key":"9631_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41390-020-1074-4","volume":"88","author":"RM Patel","year":"2020","unstructured":"Patel RM, Ferguson J, McElroy SJ, Khashu M, Caplan MS. Defining necrotizing enterocolitis: current difficulties and future opportunities. Pediatr Res. 2020;88(Suppl 1):10\u20135.","journal-title":"Pediatr Res"},{"issue":"1","key":"9631_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13063-025-09387-4","volume":"27","author":"JJ Petersen","year":"2025","unstructured":"Petersen JJ, Kamp CB, Olsen MH, Hansen ML, Thorlund K, Pellicer A, et al. Treatment guided by cerebral oximetry in mechanically ventilated newborns: a statistical analysis plan for step one of the SafeBoosC-IIIv randomised clinical trial. Trials. 2025;27(1):72.","journal-title":"Trials"},{"key":"9631_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2288-14-34","volume":"14","author":"JC Jakobsen","year":"2014","unstructured":"Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14:34.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"9631_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials\u2013a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162.","journal-title":"BMC Med Res Methodol"},{"key":"9631_CR26","unstructured":"Hein-Nielsen AL, Petersen SM, Greisen G. Unchanged incidence of necrotising enterocolitis in a tertiary neonatal department 2015. Available from: https:\/\/ugeskriftet.dk\/dmj\/unchanged-incidence-necrotising-enterocolitis-tertiary-neonatal-department."},{"key":"9631_CR27","unstructured":"Statistics Denmark. Statistics Denmark 2023. Available from: https:\/\/www.dst.dk\/en."},{"issue":"1","key":"9631_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13063-020-4206-6","volume":"21","author":"ML Hansen","year":"2020","unstructured":"Hansen ML, Rasmussen MI, Rubin S, Pellicer A, Cheng G, Xu X, et al. Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III. Trials. 2020;21(1):356.","journal-title":"Trials"},{"issue":"1","key":"9631_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12874-021-01344-4","volume":"21","author":"MH Olsen","year":"2021","unstructured":"Olsen MH, Hansen ML, Safi S, Jakobsen JC, Greisen G, Gluud C. Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approach. BMC Med Res Methodol. 2021;21(1):160.","journal-title":"BMC Med Res Methodol"},{"key":"9631_CR30","unstructured":"European Medicines Agency, Committee for Human Medicinal Products. Guideline on good clinical practice E6(R2). 2017."},{"issue":"2","key":"9631_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S2352-4642(24)00328-6","volume":"9","author":"BJ Manley","year":"2025","unstructured":"Manley BJ, McKinlay CJD, Lee KJ, Groom KM, Whitehead CL. Adapt to survive and thrive: the time is now for adaptive platform trials for preterm birth. Lancet Child Adolesc Health. 2025;9(2):131\u20137.","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"9631_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jama.2021.22507","volume":"327","author":"JJH Park","year":"2022","unstructured":"Park JJH, Detry MA, Murthy S, Guyatt G, Mills EJ. How to use and interpret the results of a platform trial: users\u2019 guide to the medical literature. JAMA. 2022;327(1):67\u201374.","journal-title":"JAMA"},{"issue":"3","key":"9631_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1740774515626362","volume":"13","author":"BR Saville","year":"2016","unstructured":"Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials. 2016;13(3):358\u201366.","journal-title":"Clin Trials"},{"key":"9631_CR34","unstructured":"Perner A, Kj\u00e6r MBN, Thorsen-Meyer HC, Kaas-Hansen BS, Munch MW, Collet MO, et al. Platform trials. Ugeskr L\u00e6ger. 2023;185(41):V04230237."},{"issue":"1","key":"9631_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.therap.2022.11.011","volume":"78","author":"M Roustit","year":"2023","unstructured":"Roustit M, Demarcq O, Laporte S, Barthelemy P, Chassany O, Cucherat M, et al. Platform trials. Therapie. 2023;78(1):19\u201328.","journal-title":"Therapie"},{"issue":"10","key":"9631_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","volume":"18","author":"Adaptive Platform Trials Coalition","year":"2019","unstructured":"Adaptive Platform Trials Coalition. Adaptive platform trials: definition, design, conduct and reporting considerations. Nat Rev Drug Discov. 2019;18(10):797\u2013807.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09631-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:13:11Z","timestamp":1776996791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09631-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9631"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09631-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol is approved by the Danish Research Ethics Committees (2402572). All neonatal intensive care units must have their eligibility confirmed, and the protocol should be approved by the relevant ethics committee before randomisation can begin. Prior informed consent, deferred consent, or absence of opt-out to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TS is the president of Polish Neonatal Society. He has received speakers\u2019 honouraria from the following companies: Masimo, Medtronic, AstraZeneca, Sanofi. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {7b}"}}],"article-number":"318"}}